Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure

被引:24
作者
Valbusa, Filippo [1 ]
Bonapace, Stefano [2 ]
Grillo, Cristina [1 ]
Scala, Luca [1 ]
Chiampan, Andrea [2 ]
Rossi, Andrea [3 ]
Zoppini, Giacomo [4 ]
Lonardo, Amedeo [5 ]
Arcaro, Guido [1 ]
Byrne, Christopher D. [6 ,7 ]
Targher, Giovanni [4 ]
机构
[1] Sacro Cuore Hosp, Div Gen Med, Negrar, VR, Italy
[2] Sacro Cuore Hosp, Div Cardiol, Negrar, VR, Italy
[3] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Cardiol Sect, Verona, Italy
[4] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Piazzale Stefani 1, I-37126 Verona, Italy
[5] Azienda USL Modena, NOCSAE Baggiovara, Internal Med & Outpatient Liver Clin, Modena, Italy
[6] Univ Southampton, Fac Med, Nutr & Metab, Southampton SO9 5NH, Hants, England
[7] Univ Southampton, NIHR Biomed Res Ctr, Southampton, Hants, England
关键词
GAMMA-GLUTAMYL-TRANSFERASE; ATRIAL-FIBRILLATION; RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; HOSPITALIZED-PATIENTS; RISK; COMPLICATIONS; DIAGNOSIS; NAFLD; DYSFUNCTION;
D O I
10.1097/MD.0000000000002760
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Repeat hospitalization due to acute heart failure (HF) is a global public health problem that markedly impacts on health resource use. Identifying novel predictors of rehospitalization would help physicians to determine the optimal postdischarge plan for preventing HF rehospitalization. Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for many heart diseases, including HF. We assessed whether NAFLD at hospital admission predicts 1-year all-cause rehospitalization in patients with acute HF.We enrolled all patients consecutively admitted for acute HF to our General Medicine Division, from January 2013 to April 2014, after excluding patients with acute myocardial infarction, severe heart valve diseases, malignancy, known liver diseases, and those with volume overload related to extracardiac causes. NAFLD was diagnosed by ultrasonography and exclusion of competing etiologies. The primary outcome of the study was the 1-year all-cause rehospitalization rate.Among the 107 patients enrolled in the study, the cumulative rehospitalization rate was 12.1% at 1 month, 25.2% at 3 months, 29.9% at 6 months, and 38.3% at 1 year. Patients with NAFLD had markedly higher 1-year rehospitalization rates than those without NAFLD (58% vs 21% at 1 y; P<0.001 by the log-rank test). Cox regression analysis revealed that NAFLD was associated with a 5.5-fold increased risk of rehospitalization (adjusted hazard ratio 5.56, 95% confidence interval 2.46-12.1, P<0.001) after adjustment for multiple HF risk factors and potential confounders.In conclusion, NAFLD was independently associated with higher 1-year rehospitalization in patients hospitalized for acute HF.
引用
收藏
页数:7
相关论文
共 33 条
[1]
Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort [J].
Alonso, Alvaro ;
Misialek, Jeffrey R. ;
Amiin, Mohamed A. ;
Hoogeveen, Ron C. ;
Chen, Lin Y. ;
Agarwal, Sunil K. ;
Loehr, Laura R. ;
Soliman, Elsayed Z. ;
Selvin, Elizabeth .
HEART, 2014, 100 (19) :1511-1516
[2]
Liver Abnormalities in Cardiac Diseases and Heart Failure [J].
Alvarez, Alicia M. ;
Mukherjee, Debabrata .
INTERNATIONAL JOURNAL OF ANGIOLOGY, 2011, 20 (03) :135-142
[3]
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].
Anstee, Quentin M. ;
Targher, Giovanni ;
Day, Christopher P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344
[4]
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease [J].
Armstrong, Matthew J. ;
Adams, Leon A. ;
Canbay, Ali ;
Syn, Wing-Kin .
HEPATOLOGY, 2014, 59 (03) :1174-1197
[5]
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications [J].
Ballestri, Stefano ;
Romagnoli, Dante ;
Nascimbeni, Fabio ;
Francica, Giampiero ;
Lonardo, Amedeo .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (05) :603-627
[6]
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial [J].
Blair, John E. A. ;
Pang, Peter S. ;
Schrier, Robert W. ;
Metra, Marco ;
Traver, Brian ;
Cook, Thomas ;
Campia, Umberto ;
Ambrosy, Andrew ;
Burnett, John C., Jr. ;
Grinfeld, Liliana ;
Maggioni, Aldo P. ;
Swedberg, Karl ;
Udelson, James E. ;
Zannad, Faiez ;
Konstam, Marvin A. ;
Gheorghiade, Mihai .
EUROPEAN HEART JOURNAL, 2011, 32 (20) :2563-2572
[7]
Renal Function, Health Outcomes, and Resource Utilization in Acute Heart Failure A Systematic Review [J].
Butler, Javed ;
Chirovsky, Diana ;
Phatak, Hemant ;
McNeill, Anne ;
Cody, Robert .
CIRCULATION-HEART FAILURE, 2010, 3 (06) :726-745
[8]
NAFLD: A multisystem disease [J].
Byrne, Christopher D. ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2015, 62 :S47-S64
[9]
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis [J].
Damman, Kevin ;
Valente, Mattia A. E. ;
Voors, Adriaan A. ;
O'Connor, Christopher M. ;
van Veldhuisen, Dirk J. ;
Hillege, Hans L. .
EUROPEAN HEART JOURNAL, 2014, 35 (07) :455-+
[10]
Décarie PO, 2011, INSIGHTS IMAGING, V2, P533, DOI 10.1007/s13244-011-0112-5